Kelly Culwell - Net Worth and Insider Trading

Kelly Culwell Net Worth

The estimated net worth of Kelly Culwell is at least $1 dollars as of 2024-11-13. Kelly Culwell is the Chief Medical Officer of Evofem Biosciences Inc and owns about 104 shares of Evofem Biosciences Inc (EVFM) stock worth over $1. Details can be seen in Kelly Culwell's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kelly Culwell has not made any transactions after 2020-05-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kelly Culwell

To

Kelly Culwell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kelly Culwell owns 1 companies in total, including Evofem Biosciences Inc (EVFM) .

Click here to see the complete history of Kelly Culwell’s form 4 insider trades.

Insider Ownership Summary of Kelly Culwell

Ticker Comapny Transaction Date Type of Owner
EVFM Evofem Biosciences Inc 2020-05-01 Chief Medical Officer

Kelly Culwell Latest Holdings Summary

Kelly Culwell currently owns a total of 1 stock. Kelly Culwell owns 104 shares of Evofem Biosciences Inc (EVFM) as of May 1, 2020, with a value of $1.

Latest Holdings of Kelly Culwell

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EVFM Evofem Biosciences Inc 2020-05-01 104 0.01 1

Holding Weightings of Kelly Culwell


Kelly Culwell Form 4 Trading Tracker

According to the SEC Form 4 filings, Kelly Culwell has made a total of 3 transactions in Evofem Biosciences Inc (EVFM) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Evofem Biosciences Inc is the sale of 1 shares on May 1, 2020, which brought Kelly Culwell around $9,420.

Insider Trading History of Kelly Culwell

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kelly Culwell Trading Performance

GuruFocus tracks the stock performance after each of Kelly Culwell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kelly Culwell is 61.29%. GuruFocus also compares Kelly Culwell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kelly Culwell within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kelly Culwell's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kelly Culwell

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 68.2 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 65.94 LIMIT LIMIT LIMIT LIMIT LIMIT

Kelly Culwell Ownership Network

Ownership Network List of Kelly Culwell

No Data

Ownership Network Relation of Kelly Culwell

Insider Network Chart

Kelly Culwell Owned Company Details

What does Evofem Biosciences Inc do?

Who are the key executives at Evofem Biosciences Inc?

Kelly Culwell is the Chief Medical Officer of Evofem Biosciences Inc. Other key executives at Evofem Biosciences Inc include Chief Financial Officer Yan Zhang , director & 10 percent owner Kim P. Kamdar , and Chief Commercial Officer Atkinson Katherine Cocca .

Evofem Biosciences Inc (EVFM) Insider Trades Summary

Over the past 18 months, Kelly Culwell made no insider transaction in Evofem Biosciences Inc (EVFM). Other recent insider transactions involving Evofem Biosciences Inc (EVFM) include a net sale of 104 shares made by Yan Zhang , and a net sale of 10 shares made by Kim P. Kamdar .

In summary, during the past 3 months, insiders sold 0 shares of Evofem Biosciences Inc (EVFM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 114 shares of Evofem Biosciences Inc (EVFM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 114 shares.

Evofem Biosciences Inc (EVFM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Evofem Biosciences Inc Insider Transactions

No Available Data

Kelly Culwell Mailing Address

Above is the net worth, insider trading, and ownership report for Kelly Culwell. You might contact Kelly Culwell via mailing address: C/o Evofem Biosciences, Inc., 12400 High Bluff Drive, Suite 600, San Diego Ca 92130.